Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Feasibility study of sentinel lymph node biopsy guided by indocyanine green fluorescence imaging for colon cancer - Sentinel node biopsy guided by indocyanine green fluorescence imaging for colon cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029159

Enrollment

Registered

2017-10-01

Start date

2017-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colon cancer

Interventions

During cololectomy, Indocyanine green is submucosally injected via endoscopy around tumor and sentinel lymph nodes are picked up using indocyanine green fluorescence imaging.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Histologically proven adenocarcinoma of colon or rectum adenocarcinoma. 2) solitary tumor. 3) cT2 or cT3 or cT4a or cT4b. 4) cN0. 5) D3 lymph node dissection is planned to be performed. 6) Age of 20 years or older. 7) No history of colorectomy. 8) Written informed consent.

Exclusion criteria

Exclusion criteria: 1) Allergy for indocyanine green or iodine. 2) Cannot enroll to this study for any other reasons.

Design outcomes

Primary

Measure	Time frame
The identification rate of sentinel lymph node	—

Countries

Japan

Contacts

Public ContactHidekazu Takahashi

Osaka University Department of Gastroenterological Surgery

htakahashi@gesurg.med.osaka-u.ac.jp+81-6-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026